ivabradine has been researched along with amlodipine in 2 studies
| Studies (ivabradine) | Trials (ivabradine) | Recent Studies (post-2010) (ivabradine) | Studies (amlodipine) | Trials (amlodipine) | Recent Studies (post-2010) (amlodipine) |
|---|---|---|---|---|---|
| 1,143 | 197 | 833 | 4,200 | 1,504 | 1,671 |
| Protein | Taxonomy | ivabradine (IC50) | amlodipine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1C | Cavia porcellus (domestic guinea pig) | 1.2 | |
| Potassium channel subfamily K member 2 | Homo sapiens (human) | 0.4 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.602 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.8 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.898 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 5.521 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 2.7 | |
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | 0.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ford, I; Fox, KM; Ruzyllo, W; Tendera, M | 1 |
| Ferguson, K; Klibanov, OM; Phan, D | 1 |
1 trial(s) available for ivabradine and amlodipine
| Article | Year |
|---|---|
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Topics: Aged; Amlodipine; Angina Pectoris; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Exercise Tolerance; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Myocardial Ischemia; Nitrates | 2007 |
1 other study(ies) available for ivabradine and amlodipine
| Article | Year |
|---|---|
Drug updates and approvals: 2015 in review.
Topics: Amlodipine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Atazanavir Sulfate; Azabicyclo Compounds; Benzazepines; Ceftazidime; Cobicistat; Drug Approval; Drug Combinations; Humans; Injections, Subcutaneous; Ivabradine; Liraglutide; Nurse Practitioners; Perindopril; Pyridines; Thiazoles; United States; United States Food and Drug Administration | 2015 |